PROGENICS PHARMACEUTICALS IN

CUSIP: 743187106 Class: CMN

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 56,543 Value ($000) $336 Avg Close — Range —
Q2 2017
Shares 144,743 Value ($000) $983 Avg Close — Range —
Q4 2016
Shares 18,890 Value ($000) $163 Avg Close — Range —
Q2 2016
Shares 13,100 Value ($000) $55 Avg Close — Range —
Q1 2016
Shares 388,300 Value ($000) $1,693 Avg Close — Range —
Q4 2015
Shares 434,723 Value ($000) $2,665 Avg Close — Range —
Q3 2015
Shares 477,824 Value ($000) $2,733 Avg Close — Range —
Q2 2015
Shares 313,790 Value ($000) $2,341 Avg Close — Range —
Q1 2015
Shares 185,591 Value ($000) $1,110 Avg Close — Range —
Q4 2014
Shares 41,377 Value ($000) $313 Avg Close — Range —
Q3 2014
Shares 20,880 Value ($000) $108 Avg Close — Range —
Q1 2014
Shares 10,080 Value ($000) $41 Avg Close — Range —